AI-generated summary
The authors randomized 42 patients undergoing autologous or allogeneic bone marrow transplantation to low-level laser therapy or control to test whether it prevents conditioning-induced oral mucositis. They report that 57.1% of the laser group had no oral mucositis versus 4.8% of controls, and conclude that LLLT is a powerful tool for reducing mucositis incidence.
- Participants
- 42
- Who or what was studied
- Patients undergoing autologous or allogeneic hematopoietic stem cell transplantation
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe blinding, allocation concealment, or follow-up details, and the sample is modest in size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 40 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Oral mucositis, GRADE, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.